PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 134 filers reported holding PDL BIOPHARMA INC in Q1 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $127,000 | -38.3% | 40,402 | -42.8% | 0.00% | -33.3% |
| Q2 2020 | $206,000 | -44.3% | 70,622 | -38.0% | 0.00% | +50.0% |
| Q4 2019 | $370,000 | -35.3% | 113,986 | -56.9% | 0.00% | -60.0% |
| Q3 2019 | $572,000 | +20.7% | 264,622 | +75.2% | 0.01% | 0.0% |
| Q2 2019 | $474,000 | -7.4% | 151,020 | +9.6% | 0.01% | 0.0% |
| Q1 2019 | $512,000 | +232.5% | 137,734 | +158.9% | 0.01% | +150.0% |
| Q4 2018 | $154,000 | -31.6% | 53,195 | -37.8% | 0.00% | -33.3% |
| Q3 2018 | $225,000 | -40.0% | 85,543 | -46.6% | 0.00% | -40.0% |
| Q2 2018 | $375,000 | +11.3% | 160,075 | +39.6% | 0.01% | 0.0% |
| Q1 2018 | $337,000 | +287.4% | 114,700 | +261.3% | 0.01% | +150.0% |
| Q4 2017 | $87,000 | +10.1% | 31,746 | +36.8% | 0.00% | 0.0% |
| Q3 2017 | $79,000 | -66.5% | 23,214 | -79.2% | 0.00% | -80.0% |
| Q4 2016 | $236,000 | +237.1% | 111,390 | +435.5% | 0.01% | +100.0% |
| Q3 2016 | $70,000 | -59.5% | 20,800 | -57.6% | 0.01% | -73.7% |
| Q4 2015 | $173,000 | – | 49,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |